PtdIns-(3,4,5)-P3 (1,2-dihydroxy) (sodium salt) 500 µg | ≥95% Cayman Chemical A glycerophosphoinositol More Information Supplier Page × PtdIns-(3,4,5)-P3 (1,2-dihydroxy) (sodium salt)
PtdIns-(3,4,5)-P3 (1,2-dihydroxy) (sodium salt) 100 µg | ≥95% Cayman Chemical A glycerophosphoinositol More Information Supplier Page × PtdIns-(3,4,5)-P3 (1,2-dihydroxy) (sodium salt)
PtdIns-(3,4,5)-P3 (1,2-dihydroxy) (sodium salt) 1 mg | ≥95% Cayman Chemical A glycerophosphoinositol More Information Supplier Page × PtdIns-(3,4,5)-P3 (1,2-dihydroxy) (sodium salt)
PtdIns-(4,5)-P2 (1,2-dihydroxy) (sodium salt) 500 µg | ≥95% Cayman Chemical A glycerophosphoinositol More Information Supplier Page × PtdIns-(4,5)-P2 (1,2-dihydroxy) (sodium salt)
PtdIns-(4,5)-P2 (1,2-dihydroxy) (sodium salt) 100 µg | ≥95% Cayman Chemical A glycerophosphoinositol More Information Supplier Page × PtdIns-(4,5)-P2 (1,2-dihydroxy) (sodium salt)
PtdIns-(4,5)-P2 (1,2-dihydroxy) (sodium salt) 1 mg | ≥95% Cayman Chemical A glycerophosphoinositol More Information Supplier Page × PtdIns-(4,5)-P2 (1,2-dihydroxy) (sodium salt)
GSK3685032 25 mg | ≥98% Cayman Chemical A DNMT1 inhibitor More Information Supplier Page × GSK3685032
GSK3685032 10 mg | ≥98% Cayman Chemical A DNMT1 inhibitor More Information Supplier Page × GSK3685032
